Cabaletta Bio, Inc. (CABA)

NASDAQ: CABA · IEX Real-Time Price · USD
17.06
-0.09 (-0.52%)
At close: Mar 28, 2024, 4:00 PM
17.35
+0.29 (1.70%)
After-hours: Mar 28, 2024, 7:13 PM EDT

Total Valuation

Cabaletta Bio has a market cap or net worth of $827.34 million. The enterprise value is $591.11 million.

Market Cap 827.34M
Enterprise Value 591.11M

Important Dates

The last earnings date was Thursday, March 21, 2024, before market open.

Earnings Date Mar 21, 2024
Ex-Dividend Date n/a

Share Statistics

Cabaletta Bio has 48.24 million shares outstanding. The number of shares has increased by 47.69% in one year.

Shares Outstanding 48.24M
Shares Change (YoY) +47.69%
Shares Change (QoQ) +7.65%
Owned by Insiders (%) 3.14%
Owned by Institutions (%) 101.54%
Float 39.40M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 3.50
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 15.29, with a Debt / Equity ratio of 0.02.

Current Ratio 15.29
Quick Ratio n/a
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -40.80% and return on invested capital (ROIC) is -30.95%.

Return on Equity (ROE) -40.80%
Return on Assets (ROA) -37.90%
Return on Capital (ROIC) -30.95%
Revenue Per Employee n/a
Profits Per Employee -$670,050
Employee Count 101
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +126.26% in the last 52 weeks. The beta is 2.46, so Cabaletta Bio's price volatility has been higher than the market average.

Beta (1Y) 2.46
52-Week Price Change +126.26%
50-Day Moving Average 21.31
200-Day Moving Average 16.98
Relative Strength Index (RSI) 30.82
Average Volume (30 Days) 918,960

Short Selling Information

The latest short interest is 7.09 million, so 14.70% of the outstanding shares have been sold short.

Short Interest 7.09M
Short Previous Month 7.01M
Short % of Shares Out 14.70%
Short % of Float 18.00%
Short Ratio (days to cover) 8.10

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -74.66M
Pretax Income -67.68M
Net Income -67.68M
EBITDA -64.18M
EBIT -67.68M
Earnings Per Share (EPS) -$1.65
Full Income Statement

Balance Sheet

The company has $241.25 million in cash and $5.02 million in debt, giving a net cash position of $236.23 million or $4.90 per share.

Cash & Cash Equivalents 241.25M
Total Debt 5.02M
Net Cash 236.23M
Net Cash Per Share $4.90
Equity / Book Value 236.20M
Book Value Per Share 4.90
Working Capital 228.50M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$53.55 million and capital expenditures -$687,000, giving a free cash flow of -$54.24 million.

Operating Cash Flow -53.55M
Capital Expenditures -687,000
Free Cash Flow -54.24M
FCF Per Share -$1.27
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Cabaletta Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -47.69%
Shareholder Yield -47.69%
Earnings Yield -8.18%
FCF Yield -6.56%

Analyst Forecast

The average price target for Cabaletta Bio is $32.88, which is 92.73% higher than the current price. The consensus rating is "Strong Buy".

Price Target $32.88
Price Target Difference 92.73%
Analyst Consensus Strong Buy
Analyst Count 8
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -41.86%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 3